Evidence map›Paper›PMID 29761883›Full record

ArticleCPT: pharmacometrics & systems pharmacology2018

Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance.

Andrew M Stein, Michael Looby

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Pharmacometrics and/or Systems Pharmacology.CPT: pharmacometrics & systems pharmacology · 2019
    Article
  9. QSP Versus the Rest: Let the Competition Commence!CPT: pharmacometrics & systems pharmacology · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Andrew M SteinNovartis Institute for Biomedical Research, Cambridge, Massachusetts, USA.
Michael LoobyNovartis Pharma AG, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative Systems Pharmacology (QSP) models provide a means of integrating knowledge into a quantitative framework and, ideally, this integration leads to a better understanding of biology and better predictions of new experiments and clinical trials. In practice, these goals may be compromised by model complexity and uncertainty. To address these problems, we recommend that the predictive performance of QSP models be assessed through comparison with simpler models developed specifically for this purpose.

Indexed as

BenchmarkingModels, ChemicalAntineoplastic AgentsDrug DiscoveryHeartHIVLiverPharmacokineticsRNA, ViralTemperatureVirus ReplicationAntineoplastic AgentsRNA, Viral

Identifiers

PMID29761883
PMCPMC6118293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.